Fiera Capital (Canada)
RPRX icon

Fiera Capital (Canada)’s Royalty Pharma RPRX Stock Holding History

Fiera Capital (Canada)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-36,375
Closed -$1.46M – 560
2022
Q3 		$1.46M Sell
36,375
-8,275
-19% -$353K 0.01% 339
2022
Q2 		$1.88M Sell
44,650
-3,535
-7% -$145K 0.01% 324
2022
Q1 		$1.88M Sell
48,185
-20,300
-30% -$797K ﹤0.01% 344
2021
Q4 		$2.73M Buy
68,485
+8,530
+14% +$331K 0.01% 283
2021
Q3 		$2.17M Buy
+59,955
New +$2.33M 0.01% 288

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fiera Capital (Canada)'s RPRX Position: Q4 2022 in Review

Fiera Capital (Canada) sold out of Royalty Pharma (RPRX) in Q4 2022, closing a stake of 36,375 shares — an estimated $1.46M sold.

Fiera Capital (Canada) first reported a position in RPRX in Q3 2021 and held it in 5 quarters. The position peaked at $2.73M in Q4 2021. 334 funds tracked by Wall St. Rank hold RPRX as of Q4 2022.

  • Fiera Capital (Canada) reported no remaining Royalty Pharma position as of Q4 2022 after selling out during the quarter.
  • Fiera Capital (Canada) sold 36,375 Royalty Pharma shares in Q4 2022, an estimated $1.46M.
  • Fiera Capital (Canada) first reported a position in Royalty Pharma in Q3 2021 and held it in 5 quarters.
  • Fiera Capital (Canada)'s Royalty Pharma position peaked at $2.73M in Q4 2021.
  • 334 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2022.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2022, filed 8 Feb 2023.